Medium materiality6/10
Oscar Health price target raised to $33 from $27 at Baird
Why it may matterVerify against the original reporting
Upside remains modestly positive.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside remains modestly positive.
What happened, with direct paths to the underlying reporting
Robert W. Baird raises OSCR target to $33; current price $32.34; priceChangeSinceSignal: 1.24.
Target: $33
Posted price: $32.34
Analyst firm: Robert W. Baird
Analyst: Michael Ha
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.